Scenario:
An organization is developing a powerful general-purpose AI (GPAI) model that has systemic impact. The compliance team is assessing what legal obligations apply under the EU AI Act.
Under the EU AI Act, which of the following compliance actions applies only to General Purpose AI models with systemic risk?

• A.Publishing a detailed summary of the data used to train the model
• B.Maintaining up-to-date technical documentation, including testing details
• C.Implementing an intellectual property policy to comply with EU copyright laws
• D.Making information available to downstream providers who integrate the model into their AI systems

Comment: *

Name: *

Email: *

Verification: *

After completing model testing and validation, which of the following is the most important step that an organization takes prior to deploying the model into production?

• A.Perform a readiness assessment.
• B.Define a model-validation methodology.
• C.Document maintenance teams and processes.
• D.Identify known edge cases to monitor post-deployment.

Comment: *

Name: *

Email: *

Verification: *

CASE STUDY
Please use the following answer the next question:
A mid-size US healthcare network has decided to develop an Al solution to detect a type of cancer that is most likely arise in adults. Specifically, the healthcare network intends to create a recognition algorithm that will perform an initial review of all imaging and then route records a radiologist for secondary review pursuant agreed-upon criteria (e.g., a confidence score below a threshold).
To date, the healthcare network has taken the following steps: defined its Al ethical principles: conducted discovery to identify the intended uses and success criteria for the system: established an Al governance committee; assembled a broad, crossfunctional team with clear roles and responsibilities; and created policies and procedures to document standards, workflows, timelines and risk thresholds during the project.
The healthcare network intends to retain a cloud provider to host the solution and a consulting firm to help develop the algorithm using the healthcare network's existing data and de-identified data that is licensed from a large US clinical research partner.
In the design phase, which of the following steps is most important in gathering the data from the clinical research partner?

• A.Perform a privacy impact assessment.
• B.Combine only anonymized data.
• C.Segregate the data sets.
• D.Review the terms of use.

Comment: *

Name: *

Email: *

Verification: *

What is the primary purpose of an Al impact assessment?

• A.To define and evaluate the legal risks associated with developing an Al system.
• B.Anticipate and manage the potential risks and harms of an Al system.
• C.To define and document the roles and responsibilities of Al stakeholders.
• D.To identify and measure the benefits of an Al system.

Comment: *

Name: *

Email: *

Verification: *

A shipping service based in the US is looking to expand its operations into the EU. It utilizes an in-house developed multimodal AI model that analyzes all personal data collected from shipping senders and recipients, and optimizes shipping routes and schedules based on this data.
As they expand into the EU, all of the following descriptions should be included in the technical documentation for their AI model EXCEPT?

• A.A general description of the AI system.
• B.A description of the prioritization of the risks of deployment of the AI system.
• C.A description of the appropriateness of the performance metrics for the specific AI system.
• D.A detailed description of the elements of the AI system and of the process for its development.

Comment: *

Name: *

Email: *

Verification: *